Myeloma Treatment Decisions: Insist on Essential Testing

Myeloma Treatment Decisions: Insist on Essential Testing

/in , , , , , , , , /by

In this podcast, myeloma expert Dr. Amrita Krishnan explains the essential testing that should follow a diagnosis, how the results could impact myeloma therapy, and discusses new and emerging treatments.

Dr. Amrita Krishnan is Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope in Duarte, CA. Learn more about Dr. Krishnan: https://www.cityofhope.org/people/krishnan-amrita.

Don’t miss an episode and subscribe to PEN’s Empowered! Podcast wherever podcasts are available.

You might also like
How is Treatment Fitness Determined in Multiple Myeloma?How is Treatment Fitness Determined in Multiple Myeloma?
What Should Myeloma Patients Ask About Developing ResearchWhat Should Myeloma Patients Ask About Developing Research?
Path to Empowerment Multiple Myeloma TreatmentPath to Empowerment: Multiple Myeloma | Treatment
What Testing Is Appropriate for People With Smoldering MyelomaWhat Testing Is Appropriate for People With Smoldering Myeloma?
How Do Nurses and Allied Professionals Help in Myeloma Clinical Trial SettingsHow Do Nurses and Allied Professionals Help in Myeloma Clinical Trial Settings?
Stem Cell Transplants for Myeloma: An UpdateStem Cell Transplants for Myeloma: An Update